Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
Authors
Keywords
Post-transplant lymphoproliferative disorder, PTLD, Rituximab, Adoptive T cell therapy
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 19, Issue 7, Pages -
Publisher
Springer Nature
Online
2018-05-24
DOI
10.1007/s11864-018-0549-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- DA-EPOCH-R for post-transplant lymphoproliferative disorders
- (2017) Christin B. DeStefano et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
- (2017) Ralf U. Trappe et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review
- (2016) M. A. AlDabbagh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features
- (2016) J. Finalet Ferreiro et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy
- (2016) Mira Choi et al. TRANSPLANTATION
- The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
- (2015) M. R. Luskin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- How I treat posttransplant lymphoproliferative disorders
- (2015) D. Dierickx et al. BLOOD
- Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study
- (2015) M Wu et al. BONE MARROW TRANSPLANTATION
- Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment
- (2015) Maria Raffaella Petrara et al. CANCER LETTERS
- Adapted Treatment of Epstein-Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation
- (2014) S. Choquet et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders
- (2013) J. Morscio et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
- (2013) A. M. Evens et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation
- (2013) U. D. Allen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases
- (2013) J Sanz et al. BONE MARROW TRANSPLANTATION
- Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
- (2013) Jan Styczynski et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
- (2013) M. Uhlin et al. HAEMATOLOGICA
- Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases
- (2013) An Herreman et al. LEUKEMIA & LYMPHOMA
- Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors
- (2013) Daan Dierickx et al. LEUKEMIA & LYMPHOMA
- Posttransplant Lymphoproliferative Disorder of the Central Nervous System
- (2013) Christian Kempf et al. PATHOBIOLOGY
- EBV and posttransplantation lymphoproliferative disease: what to do?
- (2013) H. Zimmermann et al. Hematology-American Society of Hematology Education Program
- Early Posttransplant Lymphoproliferative Disease
- (2012) Beverly P. Nelson et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- How I treat HHV8/KSHV-related diseases in posttransplant patients
- (2012) G. Riva et al. BLOOD
- Burkitt post-transplantation lymphoma in adult solid organ transplant recipients
- (2012) Heiner Zimmermann et al. CANCER
- Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations
- (2012) Deepa Jagadeesh et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder
- (2012) Krzysztof Czyzewski et al. LEUKEMIA & LYMPHOMA
- T-cell therapy in the treatment of post-transplant lymphoproliferative disease
- (2012) Catherine M. Bollard et al. Nature Reviews Clinical Oncology
- Plasmablastic Posttransplant Lymphoma
- (2012) Heiner Zimmermann et al. TRANSPLANTATION
- EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue in the Posttransplant Setting
- (2011) Sarah E. Gibson et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★
- (2011) R. Reshef et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder
- (2011) Jennifer Picarsic et al. CANCER
- Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases
- (2011) R. Trappe et al. HAEMATOLOGICA
- Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
- (2011) Ralf Trappe et al. LANCET ONCOLOGY
- Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant
- (2011) Denise K. Bonney et al. PEDIATRIC BLOOD & CANCER
- Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines
- (2010) Anne Parker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Primary central nervous system post-transplantation lymphoproliferative disorder
- (2010) Robert Cavaliere et al. CANCER
- Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder
- (2010) M. L. Gulley et al. CLINICAL MICROBIOLOGY REVIEWS
- The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders
- (2010) A. Merlo et al. HAEMATOLOGICA
- Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era
- (2010) Andrew M. Evens et al. JOURNAL OF CLINICAL ONCOLOGY
- High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder
- (2010) A. Patrick et al. JOURNAL OF NEURO-ONCOLOGY
- Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders
- (2010) Francesca Montanari et al. LEUKEMIA & LYMPHOMA
- Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?
- (2010) K. Mucha et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Progressive transition of Epstein-Barr virus associated lymphoproliferative disease subtypes with the development of lung cancer
- (2009) Kazuki Taoka et al. AMERICAN JOURNAL OF HEMATOLOGY
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Pathologic and Clinical Features of Hodgkin Lymphoma—Like Posttransplant Lymphoproliferative Disease
- (2009) Smita Krishnamurthy et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
- (2009) J. Styczynski et al. Transplant Infectious Disease
- Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder
- (2008) C. Portell et al. BLOOD
- Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology
- (2008) Efsevia Vakiani et al. HEMATOLOGICAL ONCOLOGY
- Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system
- (2007) Gretha van de Glind et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search